Blossom Health secures $20 million for expansion
Blossom Health, an AI-native telepsychiatry provider, has raised $20 million to accelerate growth and broaden access to psychiatric care. The company says the funding will support a “fresh approach” to closing persistent gaps in mental health services, particularly as demand continues to outpace available clinician capacity.
Targeting access, capacity, and speed to care
Telepsychiatry has become a critical channel for people seeking treatment, but long wait times and uneven coverage remain common. Blossom Health is positioning its platform as a way to increase throughput without sacrificing clinical quality, using AI to streamline key steps such as intake, triage, documentation, and care coordination.
While the company did not disclose detailed terms of the round in the announcement, the $20 million infusion is expected to be used to scale operations, expand clinical networks, and enhance product capabilities. AI-driven workflow tools have increasingly been adopted across healthcare to reduce administrative burden, a factor frequently cited by clinicians as a contributor to burnout and reduced patient capacity.
Growing competition in AI-enabled behavioral health
The raise comes amid intensifying competition among digital behavioral health providers and a broader push to apply AI to clinical workflows. Companies in the sector are racing to show measurable improvements in access, outcomes, and cost efficiency, while navigating privacy, safety, and regulatory expectations.
Blossom Health said it intends to use the new capital to expand availability and improve the patient experience, with an emphasis on reaching people who struggle to find timely psychiatric care through traditional channels.
Related
